The useful question is what changes for users, developers or buyers, and whether the announcement stays industry context or becomes something people can actually use.

The University of California system launched its first Regents Innovation Awards to honor faculty and partners who convert research into practical benefits. UC Berkeley named five nominees, including Professor Fyodor Urnov, whose team reduced the cost of personalized CRISPR therapies for children with genetic diseases by 90% and shortened development timelines tenfold, enabling broader clinical use.

Professor Markita Landry developed biotechnologies that avoid conventional genetic manipulation, using nanosensors to observe brain chemistry in conditions like addiction and autism. Her lab’s approach has produced disease-resistant rice and been adopted internationally, earning her a 2025 Guggenheim Prize and a 2026 Fulbright Fellowship.

Professor Jay Keasling co-founded ResVita Bio, the first startup from UC Berkeley’s Bakar Labs accelerator to file and clear an Investigational New Drug application with the FDA. The company engineers skin bacteria to produce therapeutic proteins locally, addressing rare genetic and inflammatory skin disorders without systemic drug circulation.

Elizabeth Redman Cleveland, Berkeley’s Chief Strategist for Sustainable Growth, leads the Berkeley Startup Cluster to retain innovation within the city. Her initiatives include zoning reforms, tax exemptions for R&D grants, and programs connecting local high schoolers to innovation careers, earning the cluster two awards in 2026.